Elevating Drug Development with NAMs:
Meeting the FDA’s Call for Change
The Following Presentations Are Now Available for On-Demand Access:
(view the abstracts)
Baseline Characterization as a Key Foundation to Qualification of a Liver Microphysiological System
Presented by: Rhiannon Hardwick, PhD, BMS
Elucidating Complex Drug-Drug Interaction Mechanisms of Chronic Rifampicin Exposure in Liver Tissue Chip
Presented by: Shiny Rajan, PhD, Javelin Biotech
siRNA Knockdown in HEPATOPAC: A Novel Approach for Reaction Phenotyping of Low Turnover Drug Candidates
Presented by: Karissa Cottier, PhD, BioIVT
From Bench to Roadmap: Human 3D Liver and Intestinal Models Driving Safer Drug Development
Presented by: Mehrsa Mehrabi, PhD, VivoSim Labs
From Barrier to Breakthrough: Validation and Implementation of Intestinal Organoid Monolayer for ADME
Presented by: Eugene Chen, PhD, Genentech